envelopeEmail this page

Acknowledgements

Each year, countless people at NCI, on our advisory boards, in other government agencies, and in research, professional, and advocacy organizations around the country provide their insights, perspectives, and expertise for the development of this document. Members of the Office of Science Planning and Assessment provide leadership and guidance for plan development from conceptualization to production. They work alongside the core group of NCI leaders who serve as Champions for the various priority areas and with the Office of Budget and Financial Management.

Numerous other people at NCI review drafts, provide background information, and identify new areas to explore. In 2001, some 40 individuals and organizations inside and outside NCI responded to our sweeping solicitation to the cancer community for suggestions about new scientific priority areas (Extraordinary Opportunities). In the summer of 2002, a similar number of people outside of NCI responded to our request for input to a draft of this document. All of these contributions have been invaluable in helping us develop a plan for Fiscal Year 2004 that captures the opportunities, challenges the community to new heights, and brings us closer to our goal to control or eliminate all cancers.

The following people at NCI deserve special recognition for their contributions to the development of this document.

  • In the Office of Science Planning and Assessment: Cherie Nichols, Kathie Reed, Jane Lockmuller, Kathy Sorrow, Marianne Kost, Bernard Glassman, Anne Tatem, Lisa Stevens, Samir Sauma, and D. J. Joya
  • NCI Priority Area Champions: Jeff Abrams, Rachel Ballard-Barbash, J. Carl Barrett, Martin Brown, Kenneth Buetow, Neil Caporaso, Michaele Christian, Norman Coleman, Robert Croyle, Brenda Edwards, Ellen Feigal, Harold Freeman, Robert Hiatt, Robert Hoover, Marvin Kalt, Jon Kerner, Brian Kimes, Gary Kreps, Scott Leischow, Joseph Lipscomb, Mary McCabe, Lori Minasian, Ed Monachino, Barbara Rimer, Julia Rowland, Edward Sausville, Dinah Singer, John Sogn, Robert Strausberg, and Daniel Sullivan
  • In the Office of Budget and Financial Management: Jim Dickens and Ngan Nguyen
  • In other NCI Offices and Programs: Jill Johnson, John Hartinger, Donna Bonner, Donna Kerrigan, Jim Mathews, and Paul LaMasters

Other contributors at NCI included Alan Rabson, Joseph Fraumeni, Peter Greenwald, Kelly Blake, Kevin Callahan, Buddy Clark, Larry Clark, Jim Corrigan, Barbara Croft, Andrea Denicoff, Marilyn Duncan, Kay Flemming, Leslie Ford, Barbara Galen, Louise Grochow, Ernie Hawk, John Hoffman, Jim Jacobson, Gary Kelloff, Elaine Lee, Allison Linden, Lance Liotta, Cheryl Marks, Susan McCarthy, Anne Menkens, Julie Schneider, Kara Smigel-Croker, Sudhir Srivastava, Tracy Thompson, Stacey Vandor, and Paula Zeller.

The following people and organizations outside of NCI reviewed and provided input to the draft document in the summer of 2002.

  • NCI Advisory Groups: National Cancer Advisory Board member Ralph S. Freedman; Board of Scientific Advisors member Nancy Mueller; Board of Scientific Counselors members Elizabeth Fontham, Laurence N. Kolonel, and Alice Pentland; Director's Consumer Liaison Group members Kathy Giusti, Paula Kim, Barbara LeStage, Gena Love, Karen Packer, Christopher G. Pablo, Henry Porterfield, Nyrvah Richard, and Doug Ulman; and Progress Review Group leaders Scott Kern and Nicole Urban
  • Cancer Centers and SPOREs: H. Shelton Earp, Jane Ehrke, Stephen P. Goff, Lynn Matrisian, Edward Partridge, and Kent Lloyd
  • Professional and Advocacy Organizations: Alliance for Prostate Cancer Prevention, American Association for Cancer Research, American Public Health Association, American Society for Clinical Oncology, American Society for Therapeutic Radiology and Oncology, The Children's Cause, Lymphoma Research Foundation, National Coalition for Cancer Survivorship, North American Brain Tumor Coalition, Oncology Nursing Society, Robert Wood Johnson Foundation, and Susan G. Komen Breast Cancer Foundation
  • Other Reviewers: Martin Hauer-Jensen, Deborah Mayer, Stephen Taplin, and Clare MC Tempany
  • HHS Agencies: National Institute on Aging and the Centers for Disease Control and Prevention

And special thank you's go to Suzanne Reuben of Progressive Health Systems, Sharyn Horowitz of Analytical Sciences, Inc., Rosemary Yancik of the National Institute on Aging, and Lynne Komai of The Watermark Design Office.

Top of Page